Annual accounts receivable:
N/ASummary
- ARWR annual accounts receivable is not available.
Performance
ARWR Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly accounts receivable:
$2.37M-$135.00K(-5.40%)Summary
- As of today (June 22, 2025), ARWR quarterly accounts receivable is $2.37 million, with the most recent change of -$135.00 thousand (-5.40%) on March 31, 2025.
- ARWR quarterly accounts receivable is now -96.59% below its all-time high of $69.43 million, reached on March 31, 2023.
Performance
ARWR Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ARWR Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | +79.6% |
| 5 y5 years | - | +86.8% |
ARWR Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.6% | +889.5% | ||
| 5 y | 5-year | -96.6% | +1476.7% | ||
| alltime | all time | -96.6% | >+9999.0% |
ARWR Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.37M(-5.4%) |
| Dec 2024 | - | $2.50M(+100.5%) |
| Jun 2023 | - | $1.25M(-98.2%) |
| Mar 2023 | - | $69.43M(+75.5%) |
| Dec 2022 | - | $39.57M(+2706.2%) |
| Sep 2022 | $1.41M(-86.3%) | $1.41M(+490.0%) |
| Jun 2022 | - | $239.00K(-81.9%) |
| Mar 2022 | - | $1.32M(+778.0%) |
| Dec 2021 | - | $150.00K(-98.5%) |
| Sep 2021 | $10.26M(+1112.2%) | $10.26M(+1428.3%) |
| Jun 2021 | - | $671.00K(-29.7%) |
| Mar 2021 | - | $955.00K(-89.4%) |
| Dec 2020 | - | $9.00M(+964.1%) |
| Sep 2020 | $846.00K(+27.9%) | $846.00K(-96.1%) |
| Jun 2020 | - | $21.69M(+1613.7%) |
| Mar 2020 | - | $1.27M(-5.9%) |
| Dec 2019 | - | $1.35M(+103.4%) |
| Sep 2019 | $661.40K(+102.0%) | $661.40K(-67.6%) |
| Jun 2019 | - | $2.04M(-84.8%) |
| Mar 2019 | - | $13.42M(+323.6%) |
| Dec 2018 | - | $3.17M(+867.8%) |
| Sep 2018 | $327.40K(+382.9%) | $327.40K(+2082.7%) |
| Jun 2018 | - | $15.00K(-8.0%) |
| Mar 2018 | - | $16.30K(-89.1%) |
| Dec 2017 | - | $149.90K(+121.1%) |
| Sep 2017 | $67.80K(-9.6%) | $67.80K(-92.8%) |
| Jun 2017 | - | $937.30K(+61.4%) |
| Mar 2017 | - | $580.80K(+868.0%) |
| Dec 2016 | - | $60.00K(-20.0%) |
| Sep 2016 | $75.00K(>+9900.0%) | $75.00K(>+9900.0%) |
| Sep 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2014 | - | $127.00K(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | - | $75.00K(0.0%) |
| Sep 2013 | $75.00K(+697.9%) | $75.00K(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | - | $115.30K(+1126.6%) |
| Sep 2012 | $9400.00 | $9400.00(-98.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $677.40K(+2884.1%) |
| Mar 2012 | - | $22.70K(-98.6%) |
| Sep 2011 | $1.61M(+2630.7%) | $1.61M(+19.1%) |
| Jun 2011 | - | $1.35M(+6.5%) |
| Mar 2011 | - | $1.27M(-72.4%) |
| Dec 2010 | - | $4.59M(+7688.1%) |
| Sep 2010 | $58.90K(-59.1%) | $58.90K(+520.0%) |
| Jun 2010 | - | $9500.00(-83.0%) |
| Mar 2010 | - | $55.90K(-56.9%) |
| Dec 2009 | - | $129.80K(-9.9%) |
| Sep 2009 | $144.10K(+3414.6%) | $144.10K(-63.4%) |
| Jun 2009 | - | $393.80K(+243.3%) |
| Mar 2009 | - | $114.70K(-1.5%) |
| Dec 2008 | - | $116.40K(+2739.0%) |
| Sep 2008 | $4100.00(-98.5%) | $4100.00(-95.7%) |
| Jun 2008 | - | $94.40K(+12.5%) |
| Mar 2008 | - | $83.90K(-79.1%) |
| Dec 2007 | - | $401.00K(+46.4%) |
| Sep 2007 | $273.90K(+965.8%) | $273.90K(+72.6%) |
| Jun 2007 | - | $158.70K(+4189.2%) |
| Dec 2006 | - | $3700.00(-89.2%) |
| Jun 2006 | - | $34.40K(-14.0%) |
| Mar 2006 | - | $40.00K(+33.3%) |
| Dec 2005 | - | $30.00K(+16.7%) |
| Sep 2005 | $25.70K(-50.4%) | $25.70K(-70.4%) |
| Jun 2005 | - | $86.70K(+3234.6%) |
| Dec 2004 | - | $2600.00(-95.0%) |
| Sep 2004 | $51.80K(+8533.3%) | $51.80K(>+9900.0%) |
| Jun 2002 | - | $100.00(0.0%) |
| Mar 2002 | - | $100.00(-92.9%) |
| Dec 2001 | - | $1400.00(+133.3%) |
| Sep 2001 | $600.00(-53.8%) | $600.00(-72.7%) |
| Dec 2000 | - | $2200.00(+69.2%) |
| Sep 2000 | $1300.00(-88.5%) | $1300.00(-18.8%) |
| Jun 2000 | - | $1600.00(+6.7%) |
| Mar 2000 | - | $1500.00(+36.4%) |
| Dec 1999 | - | $1100.00 |
| Sep 1999 | $11.30K(+253.1%) | - |
| Sep 1998 | $3200.00(-69.2%) | - |
| Sep 1997 | $10.40K | - |
FAQ
- What is the all time high annual accounts receivable for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arrowhead Pharmaceuticals?
What is the all time high annual accounts receivable for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual accounts receivable is $10.26M
What is Arrowhead Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of ARWR is $2.37M
What is the all time high quarterly accounts receivable for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly accounts receivable is $69.43M